| Wiki Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Writing Articles > Myths About Comparing Online Article Averages on Article Submission Websites |
|
Wiki Articles - Myths About Comparing Online Article Averages on Article Submission Websites
Many people like to compare their online article submissions with o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ther online article submission authors. And in doing so they will b ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in lieve that their popularity as a writer has something to do with th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s. It does not really and it is very unwise to believe it does. Re here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ently it was stated that if someone had 70 articles posted online a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nd I have 7000 articles online then we could compare these average ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc onsider the amount of time that each author had them up online. For easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi instance if I had my articles up for 16 months and they have had th nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically irs up for 8-months then our averages should be similar in that my and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ averages should be twice as much since they have been up for twice ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s long. Well on the surface this seems like a good idea and mathem ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tically correct however it is totally wrong and that is a complete dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod allacy. Why? Well consider that I post so many new articles it drag cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s down the averages and another author may post fewer articles and tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen hat allows their articles to move up faster on an average basis. N t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel w then if we posted at the same percentages to the total each month ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust it might seem to be relevant however also there is seasonality in I y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nternet traffic at different times of the year too and therefore th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t somewhat throw all the numbers out of wack unless we both started elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip on the same day of the same year you see? Consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:You're Killing Your Own Business P.A.P. The Basics of Pipeline Management What Kind of a Sponsor Are You?
|